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Abstract 
Purpose: To investigate the effect of 2-[(4-hydroxy-phenylamino)-methylene]-5,5-dimethyl-cyclohex 
(HPDH) on mammary carcinogenesis induced by 7,12-dimethylbenz(a)anthracene in female Sprague 
Dawley rats.   
Methods: Among three groups of rats (50 each)  used in the study, the control group was fed standard 
diet alone, ibuprofen group received standard diet containing 1200 mg/kg ibuprofen while HPDH group 
was administered standard diet containing 1200 mg/kg HPDH. The treatment was for 10 days for all the 
groups. All the animals received 20 mg of DMBA intragastrically by gavage. Clinical parameters for the 
rats were recorded weekly. Micrometer caliper was used to measure the diameter of all the tumors at 
the end of the experiment and tumor volume calculated. Histological evaluation was performed using 
hematoxylin and eosin (H&E) staining. High performance liquid chromatography (HPLC) was used to 
determine the level of HPDH and ibuprofen in the serum of the animals. 
Results: The data revealed a significant decrease in the number of rats with mammary tumor, number 
of tumors/rat and tumor volume by 54, 72 and 75 %, respectively, in HPDH group compared to control 
group. The ibuprofen-treated rats also showed significant decrease in the number of rats with tumor, 
number of tumors/rat and tumor volume by 43, 55, and 59 %, respectively. Treatment of rats with HPDH 
increased the latency period of tumor induction significantly (p < 0.005). Median detection period (50 % 
of tumors) was 92, 83 and 56 days, respectively, in HPDH, ibuprofen and control groups, respectively, 
after DMBA induction.  
Conclusion: These results demonstrate that HPDH possesses strong chemopreventive activity against 
mammary carcinogenesis. 
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In Western countries breast cancer is a most 
frequent malignant neoplasm among women. 
There were 234,580 new breast cancer cases 
detected and 40,030 estimated deaths in the 
United States alone in 2013 [1]. Despite intensive 
cancer control efforts, it remains the second 
leading cause of cancer deaths among American 
women [2].  Owing to difficulty in predicting 
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metathesis development many women are over-
treated and suffer toxic side effects of 
chemotherapy [3]. Recent epidemiological 
studies suggested the presence of an inverse 
association between regular intake of NSAIDs 
and the relative risk of breast cancer [4-6]. 
Animal studies have also demonstrated the 
effects of NSAIDs on mammary carcinogenesis 
[7,8] and in our laboratories, the common over-
the-counter drug ibuprofen produced highly 
significant reductions in tumor size and tumor 
burden associated with inhibition of the genetic 
expression of COX isoforms [9-11]. 
 
Enamides are often present in natural products 
and drug candidates. In particular, enamides and 
dienamides are common in a number of anti-
parasitic and anti-cancer natural products and 
pharmaceutical drug leads [12,13]. A typical 
example of the important role played by the 
enamide moiety in the biological activity of 
natural products is represented by the 
comparison of the IC50 of the potent anti-cancer 
agent salicylihalamide A, with two analogues. 
The derivative with intact enamide moiety 
retained its biological activity compared to that of 
the analog without enamide functionality. [14]. In 
view of the biological activity of salicylihalamide 
A, and similar functionality of test drug, the effect 
of HPDH (Fig 1) in mammary carcinogenesis in 
female Sprague Dawley rats was investigated in 
this study.  
 
 





Reagents and chemicals  
 
2-[(4-Hydroxy-phenylamino)-methylene]-5,5-
dimethyl-cyclohexanone (HPDH), of 7,12-
Dimethylbenz(α)anthracene (DMBA) and all 
other reagents of highest purity  were purchased 
from Sigma Chemical Co. (St. Louis, MO). Oral 
Ibuprofen suspension was purchased as Motrin 
(100 mg/ 5ml; McNeil).  
 
Dietary and tumor induction protocols  
 
Female Sprague Dawley rats (150 in number) 
were purchased from Central Lab Animal Inc., 
Seoul, Republic of Korea. The rats were 
randomly assigned to three groups of 50 each. 
The control group of rats were fed standard diet 
alone, another group was fed standard   diet 
containing 1200 mg/kg body weight ibuprofen 
while the third group received standard diet 
containing 1200 mg/kg body weight HPDH 
for110 days. All the animals received 20 mg of 
DMBA intragastrically by gavage. The 
experiment was terminated after 110 days and 
during this period general health of rats, weight 
gain and feed consumption were monitored. The 
animals were palpated twice a week for detection 
of mammary tumors after 28 days of DMBA 
treatment. Clinical parameters, including number 
of rats with tumor, time of first tumor appearance, 
number of tumors per rat, relative tumor size, 
and location of every tumor were recorded 
weekly. After end of experiment, a micrometer 
caliper was used to measure the diameters of all 
the tumors. From the diameter tumor volumes 
were calculated using the formula V = 4/3 π r3. 
The animals were sacrificed and gross 
examination of stomach, kidneys, and liver was 
performed. All tumors, stomach and both kidneys 
of each rat were resected and fixed in 10 % 
buffered formalin. Prior to histological evaluation 
samples were embedded in paraffin blocks. The 
histological evaluation was performed using H&E 
staining. HPLC was used to determine the level 
of HPDH and ibuprofen in the serum of animals 




Descriptive statistics on body weights, tumor 
latency, number of rats with tumor, number of 
tumors per rat, and tumor volumes were 
examined and compared among the control, 
HPDH and treatment groups. The statistical 
significance between the three treatment groups 
were obtained using students t test and one-way 
analysis of variance (ANOVA). P < 0.05 was 





Body weight  
 
There was no significant difference (p < 0.05) in 
the initial and final mean body weights of animals 
for control, ibuprofen and HPDH groups (Table 
1). 
 
Histopathology of mammary tumors 
 
The histopathological evaluation of the tumors 
excised from the rats of control, ibuprofen and 
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HPDH group showed that all the 150 tumors from 
control and 72 tumors from ibuprofen groups 
were adenocarcinomas. Among 22 tumors from 
HPDH group, 17 were adenocarcinomas, and 3 
were non-malignant fibroadenomas. 
 
Mammary tumor data 
 
The examination of rats revealed a significant 
decrease in number of rats with mammary tumor, 
number of tumors/rat and tumor volume by 54, 
72 and 75 %, respectively, in HPDH group 
compared to control group (Table 2). Out of 50 
rats in HPDH group, 17 had malignant tumors 
and 4 rats suffered from fibroadenomas. The 
tumor volume for these rats was very small. On 
the other hand, in control group all the 50 rats 
suffered from malignant tumors.  
 
Most of the rats had multiple tumors and the 
tumor volume was larger. The ibuprofen treated 
rats also showed significant decrease in number 
of rats with tumor, number of tumors per rat and 
smaller tumor volumes by 43, 55 and 59 %, 
respectively. Treatment of rats with HPDH also 
increased the latency period of tumor induction 
significantly. Median detection period (50 % of 
tumors) was 92, 83 and 56 days, respectively, in 
the rats of HPDH, ibuprofen and control group 
respectively after DMBA induction (Table 2).  
 
Pharmacological data  
 
The mean HPDH level in serum was 4.3 mg/mL. 
However, the level of HPDH in rats without tumor 
was slightly more (4.6 mg/ml) than those with 
tumor (4.1 mg/mL). The ibuprofen levels in 




As the presence of enamide moiety plays vital 
role in the anticancer activity of salicylihalamide 
A [14]. Since HPDH also possesses similar 
functionality we devised an experiment to 
investigate the effect of HPDH in the treatment of 
mammary carcinogenesis. Our results 
demonstrate that HPDH is a potential 
chemopreventic agent against the development 
of chemically induced breast cancer. The 
observed chemopreventive effects of the HPDH 
exceeded those of the ibuprofen as well as other 
agents like retinoic acid 4-HPR and the 
glucuronidase inhibitor glucarate [16] that have 
shown significant antitumor effects in this animal 
model, but were slightly less than those of 
celecoxib [17]. The exact mechanism by which 
HPDH suppresses mammary tumor is not clearly 
known but it works similar to that of ibuprofen. 
Treatment of animals with HPDH did not lead to 
any toxic effect. 
  
The animals were palpated twice a week for 
detection of mammary tumors after 28 days of 
DMBA treatment. The clinical parameters like 
number of rats with tumor, time of first tumor 
appearance, number of tumors per rat, relative 
tumor size, and location of every tumor were 
recorded weekly. A micrometer caliper was used 
to measure tumor diameters from which tumor 




Table 1: Body weight of treated Sprague Dawley rats 
 
Treatment group Initial weight (g) Final weight (g) 
Control 166.3 ± 1.7 281.1 ± 2.4 
HPDH 169.7 ± 1.5 283.6 ± 2.6 
Ibuprofen 167.4 ± 2.9 281.6 ± 1.3 
Values are mean weight ± SEM; no significant variation was observed in the means of treatment; (initial weights, 
p = 0.17; final weights, p = 0.32) 
 
Table 2: Effect of HPDH and ibuprofen on the number of rats with tumor, number of tumors per rat, and tumor 






No of rats with tumor (%) 
Cancera   All tumors  




Control 58 100 100 3.2 ± 60.2 1.56 ± 0.4 
HPDH 95f 32 (68)e 60 (40)e 1.5 ± 0.3 (52)e 0.66 ± 0.2 (57)e 
Ibuprofen 86f 60 (40)e 60 (40)e 1. 6 ± 0.4 (52)e 0.7 ± 0.3 (57)e 
a Frequency of animals that developed breast cancer; b All tumors include animals in the HPDH treatment group 
that developed fibroadenomas; c Mean number of tumors/animal 6 ± SE; d Mean tumor volume 6 ± SE; 
eStatistical significance relative to the control group at P < 0.001. % Reductions in the incidence rates, tumor 
burden, and tumor volume for the experimental diets relative to the control diet are given in parentheses 
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H&E staining was used for histological evaluation 
of the tumors and HPLC was used to determine 
the level of HPDH and ibuprofen in the serum of 
animals at completion of the experiment. All 
these results indicated that HPDH can act as 
effective therapeutic agent in the treatment of 
mammary carcinogenesis. 
 
As the presence of enamide moiety plays vital 
role in the anticancer activity of salicylihalamide 
A [14]. We investigated the role of HPDH in the 
treatment of mammary carcinogenesis. Our 
results demonstrate that HPDH is a potential 
candidate chemopreventive agent against the 
development of chemically induced breast 
cancer. The observed chemopreventive effects 
of the HPDH exceeded those of the ibuprofen as 
well as other agents like retinoic acid 4-HPR and 
the glucuronidase inhibitor glucarate [16] that 
have shown significant antitumor effects in this 
animal model, but were slightly less than those of 
celecoxib [17]. The exact mechanism by which 
HPDH suppresses mammary tumor is not clearly 
known but it works similar to that of ibuprofen. 
Treatment of animals with HPDH did not lead to 
any toxic effect. All these results indicated that 
HPDH can act as effective therapeutic agent in 




Administration of HPDH suppresses breast 
tumors induced by DMBA in female Sprague 
Dawley rats. The degree of inhibition is more 
pronounced with HPDH than with ibuprofen. 
These results suggest that HPDH may be an 
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